Unrecognized Tax Benefits of VYNE Therapeutics Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
VYNE Therapeutics Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • VYNE Therapeutics Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $2,446,000, a 4.7% decline year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

VYNE Therapeutics Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,446,000 -$120,000 -4.7% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q4 2024 $2,566,000 +$108,000 +4.4% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q4 2023 $2,458,000 -$396,000 -14% 31 Dec 2023 10-K 27 Feb 2026 2025 FY
Q4 2022 $2,854,000 +$55,000 +2% 31 Dec 2022 10-K 06 Mar 2025 2024 FY
Q4 2021 $2,799,000 -$284,000 -9.2% 31 Dec 2021 10-K 01 Mar 2024 2023 FY
Q4 2020 $3,083,000 +$2,369,000 +332% 31 Dec 2020 10-K 14 Mar 2023 2022 FY
Q4 2019 $714,000 -$176,000 -20% 31 Dec 2019 10-K 17 Mar 2022 2021 FY
Q4 2018 $890,000 +$87,000 +11% 31 Dec 2018 10-K 04 Mar 2021 2020 FY
Q4 2017 $803,000 +$574,000 +251% 31 Dec 2017 10-K 03 Mar 2020 2019 FY
Q4 2016 $229,000 +$136,000 +146% 31 Dec 2016 10-K 03 Mar 2020 2019 FY
Q4 2015 $93,000 +$20,000 +27% 31 Dec 2015 10-K 28 Feb 2019 2018 FY
Q4 2014 $73,000 31 Dec 2014 10-K 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.